Accuray Incorporated (ARAY) 7.54 $ARAY
Pathways Home Health & Hospice Hosts Prestigious Japanese Health Care Research Mission
PRWeb - Mon Dec 22, 11:00AM CST
Pathways hosted a Japanese health care research mission led by Dr. Toshiki Mano of the Taman University in Japan. This prestigious group of Japanese health-care professionals included thirteen physicians as well as a number of hospital administrators and attorneys. The purpose of this tour was to learn about best practices and innovations in health care and medical technology in the United States.
ARAY: 7.54 (+0.19)
Varian Eyes MeVis to Enhance Imaging Components Portfolio - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 18, 11:50AM CST
The acquisition of Germany-based MeVis Medical Solutions AG will add cancer screening software to Varian Medical Systems, Inc.'s (VAR) Imaging Components product portfolio.
PHG: 29.39 (-0.06), VAR: 88.44 (+0.69), ARAY: 7.54 (+0.19), PKI: 43.99 (-0.06)
Ghosts Of Business Problems Past Visit Accuray Again
Stephen Simpson, CFA - at Seeking Alpha - Wed Dec 17, 12:13PM CST
VAR: 88.44 (+0.69), ARAY: 7.54 (+0.19)
Accuray to Present at JP Morgan 33rd Annual Healthcare Conference
GlobeNewswire - Tue Dec 16, 3:02PM CST
Accuray Incorporated (Nasdaq:ARAY), announced today that its management is scheduled to present at the JP Morgan 33 Annual Healthcare Conference in San Francisco on Monday, January 12, 2015 at 4:00 p.m. PST/7:00 p.m. EST.
ARAY: 7.54 (+0.19)
Accuray Shares Down 18.3% Since SmarTrend's Sell Call (ARAY)
Comtex SmarTrend(R) - Tue Dec 16, 9:56AM CST
SmarTrend identified a Downtrend for Accuray (NASDAQ:ARAY) on July 18th, 2014 at $8.11. In approximately 5 months, Accuray has returned 18.32% as of today's recent price of $6.62.
ARAY: 7.54 (+0.19)
Varian (VAR) Now a Strong Sell on Challenging Q1 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 12:40PM CST
On Dec 11, 2014, Zacks Investment Research downgraded Varian Medical Systems (VAR) to a Zacks Rank #5 (Strong Sell).
ETRM: 1.40 (-0.01), VAR: 88.44 (+0.69), EW: 130.75 (+1.17), ARAY: 7.54 (+0.19)
Accuray Down 19.3% Since SmarTrend Downtrend Call (ARAY)
Comtex SmarTrend(R) - Tue Dec 09, 9:18AM CST
SmarTrend identified a Downtrend for Accuray (NASDAQ:ARAY) on July 18th, 2014 at $8.11. In approximately 5 months, Accuray has returned 19.31% as of today's recent price of $6.54.
ARAY: 7.54 (+0.19)
Health Care Equipment Stocks Technical Analysis - Boston Scientific, Becton Dickinson, St. Jude Medical, Accuray, and Symmetry Medical
PR Newswire - Fri Dec 05, 7:50AM CST
Investor-Edge has initiated coverage on the following equities: Boston Scientific Corporation (NYSE: BSX), Becton Dickinson and Company (NYSE: BDX), St Jude Medical Inc. (NYSE: STJ), Accuray Inc. (NASDAQ: ARAY), and Symmetry Medical Inc. (NYSE: SMA). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, December 04, 2014, the NASDAQ Composite ended at 4,769.44, down 0.11%, the Dow Jones Industrial Average edged 0.07% lower, to finish the day at 17,900.10, and the S&P 500 closed at 2,071.92, down 0.12%. The losses were broad based as seven out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 811.12, down 0.12%, while the index has advanced 10.05% in the previous three months. Register for your complimentary reports on these five stocks at:
BSX: 13.13 (+0.07), SMA: 9.27 (-0.04), BDX: 139.90 (+1.44), STJ: 66.67 (+0.67), ARAY: 7.54 (+0.19)
Insider Trading Alert - CVT, ARAY And AMGN Traded By Insiders
at The Street - Thu Dec 04, 9:15AM CST
Stocks with insider trader activity include CVT, ARAY and AMGN
CVT: 27.66 (+0.26), AMGN: 160.67 (+3.15), ARAY: 7.54 (+0.19)
Varian Medical (VAR) to Display New Technologies at RSNA - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 12:50PM CST
Varian Medical Systems (VAR) will showcase new technologies in the ongoing (Nov 30 through Dec 5) annual meet of the Radiological Society of North America (RSNA).
VAR: 88.44 (+0.69), EW: 130.75 (+1.17), ARAY: 7.54 (+0.19), ANGO: 19.19 (+0.33)
OKS, XPO, XPH, WU, MVO, ARAY Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Dec 03, 7:24AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ONEOK PARTNERS, L.P. (NYSE:OKS), XPO Logistics Inc (NYSE:XPO), Spdr S&P Pharmaceuticals Etf (NYSE:XPH), Western Union Co (NYSE:WU), MV Oil Trust (NYSE:MVO), Accuray Inc (NASDAQ:ARAY) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
WU: 18.07 (-0.05), OKE: 50.71 (+0.33), XPH: 107.77 (+1.13), OKS: 41.05 (-0.04), ARAY: 7.54 (+0.19), MVO: 14.34 (-0.60), XPO: 41.97 (-0.51)
Accuray Has Returned 18.0% Since SmarTrend Recommendation (ARAY)
Comtex SmarTrend(R) - Mon Dec 01, 5:21PM CST
SmarTrend identified a Downtrend for Accuray (NASDAQ:ARAY) on July 18th, 2014 at $8.11. In approximately 5 months, Accuray has returned 17.95% as of today's recent price of $6.65.
ARAY: 7.54 (+0.19)
Accuray and Lausanne University Hospital Join Forces to Offer Patients Personalized Radiation Therapy Treatments
PR Newswire Europe - Wed Nov 26, 9:02PM CST
- Collaboration Increases Patient Access to the CyberKnife(R) and TomoTherapy(R) Systems
ARAY: 7.54 (+0.19)
3 Reasons Obamacare Could Be Doomed in Its Second Year
Sean Williams, The Motley Fool - Motley Fool - Thu Nov 20, 8:36AM CST
Source: White House on Flickr. It's been five days since the Affordable Care Act's online marketplaces began enrolling Americans for health insurance in 2015, and perhaps the most amazing aspect of the launch thus far is that it's been largely...
CI: 104.23 (-0.08), HCA: 74.89 (-0.11), ARAY: 7.54 (+0.19), AET: 89.59 (+0.14), WLP: 128.71 (+0.94)
Accuray CyberKnife M6 System Now Available in Manhattan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 5:05PM CST
Developer of radiation therapy systems, Accuray Inc (ARAY) recently announced that Winthrop University Hospital's NYCyberKnife Center has started treating patients with the company's CyberKnife M6 System.
VAR: 88.44 (+0.69), ISR: 1.54 (+0.04), ARAY: 7.54 (+0.19)
First CyberKnife® Full-Body Radiosurgery System in Manhattan Now Treating Patients
PR Newswire - Tue Nov 18, 7:30AM CST
Accuray Incorporated (Nasdaq: ARAY) announced today that the first CyberKnife® System in Manhattan is now treating patients at Winthrop University Hospital's NYCyberKnife Center. Winthrop's decision to install the latest generation CyberKnife M6(TM) System reinforces its growing reputation as a dedicated radiosurgery device that delivers extremely precise full-body treatments while maximizing patients' quality of life during and after treatment.
ARAY: 7.54 (+0.19)
Downtrend Call Working As Accuray Stock Falls 13.0% (ARAY)
Comtex SmarTrend(R) - Fri Nov 14, 9:38AM CST
SmarTrend identified a Downtrend for Accuray (NASDAQ:ARAY) on July 18th, 2014 at $8.11. In approximately 4 months, Accuray has returned 13.02% as of today's recent price of $7.05.
ARAY: 7.54 (+0.19)
Accuray to Participate in Brean Capital's 2014 Life Science Conference
GlobeNewswire - Mon Nov 10, 3:10PM CST
Accuray Incorporated (Nasdaq:ARAY), announced today that its management is scheduled to participate in the Brean Capital 2014 Life Science Conference in New York City on Monday, November 24, 2014.
ARAY: 7.54 (+0.19)
VYCOR: "On the Cusp of the Next Big Healthcare Trend"
ACCESSWIRE - Mon Nov 10, 8:23AM CST
Vycor: "On the Cusp of the Next Big Healthcare Trend"
MDVN: 99.23 (+1.23), ABMD: 38.46 (+0.13), JNJ: 104.59 (+0.31), AMGN: 160.67 (+3.15), EXAS: 27.60 (+0.39), ARAY: 7.54 (+0.19), HOLX: 26.89 (+0.10), PBYI: 189.96 (+0.12)
Pathways Home Health & Hospice Hosts Prestigious Japanese Health Care Research Mission
PRWeb - Mon Dec 22, 11:00AM CST
Pathways hosted a Japanese health care research mission led by Dr. Toshiki Mano of the Taman University in Japan. This prestigious group of Japanese health-care professionals included thirteen physicians as well as a number of hospital administrators and attorneys. The purpose of this tour was to learn about best practices and innovations in health care and medical technology in the United States.
ARAY: 7.54 (+0.19)
Varian Eyes MeVis to Enhance Imaging Components Portfolio - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 18, 11:50AM CST
The acquisition of Germany-based MeVis Medical Solutions AG will add cancer screening software to Varian Medical Systems, Inc.'s (VAR) Imaging Components product portfolio.
PHG: 29.39 (-0.06), VAR: 88.44 (+0.69), ARAY: 7.54 (+0.19), PKI: 43.99 (-0.06)
Ghosts Of Business Problems Past Visit Accuray Again
Stephen Simpson, CFA - at Seeking Alpha - Wed Dec 17, 12:13PM CST
VAR: 88.44 (+0.69), ARAY: 7.54 (+0.19)
Accuray to Present at JP Morgan 33rd Annual Healthcare Conference
GlobeNewswire - Tue Dec 16, 3:02PM CST
Accuray Incorporated (Nasdaq:ARAY), announced today that its management is scheduled to present at the JP Morgan 33 Annual Healthcare Conference in San Francisco on Monday, January 12, 2015 at 4:00 p.m. PST/7:00 p.m. EST.
ARAY: 7.54 (+0.19)
Accuray Shares Down 18.3% Since SmarTrend's Sell Call (ARAY)
Comtex SmarTrend(R) - Tue Dec 16, 9:56AM CST
SmarTrend identified a Downtrend for Accuray (NASDAQ:ARAY) on July 18th, 2014 at $8.11. In approximately 5 months, Accuray has returned 18.32% as of today's recent price of $6.62.
ARAY: 7.54 (+0.19)
Varian (VAR) Now a Strong Sell on Challenging Q1 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 12:40PM CST
On Dec 11, 2014, Zacks Investment Research downgraded Varian Medical Systems (VAR) to a Zacks Rank #5 (Strong Sell).
ETRM: 1.40 (-0.01), VAR: 88.44 (+0.69), EW: 130.75 (+1.17), ARAY: 7.54 (+0.19)
Accuray Down 19.3% Since SmarTrend Downtrend Call (ARAY)
Comtex SmarTrend(R) - Tue Dec 09, 9:18AM CST
SmarTrend identified a Downtrend for Accuray (NASDAQ:ARAY) on July 18th, 2014 at $8.11. In approximately 5 months, Accuray has returned 19.31% as of today's recent price of $6.54.
ARAY: 7.54 (+0.19)
Health Care Equipment Stocks Technical Analysis - Boston Scientific, Becton Dickinson, St. Jude Medical, Accuray, and Symmetry Medical
PR Newswire - Fri Dec 05, 7:50AM CST
Investor-Edge has initiated coverage on the following equities: Boston Scientific Corporation (NYSE: BSX), Becton Dickinson and Company (NYSE: BDX), St Jude Medical Inc. (NYSE: STJ), Accuray Inc. (NASDAQ: ARAY), and Symmetry Medical Inc. (NYSE: SMA). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, December 04, 2014, the NASDAQ Composite ended at 4,769.44, down 0.11%, the Dow Jones Industrial Average edged 0.07% lower, to finish the day at 17,900.10, and the S&P 500 closed at 2,071.92, down 0.12%. The losses were broad based as seven out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 811.12, down 0.12%, while the index has advanced 10.05% in the previous three months. Register for your complimentary reports on these five stocks at:
BSX: 13.13 (+0.07), SMA: 9.27 (-0.04), BDX: 139.90 (+1.44), STJ: 66.67 (+0.67), ARAY: 7.54 (+0.19)
Insider Trading Alert - CVT, ARAY And AMGN Traded By Insiders
at The Street - Thu Dec 04, 9:15AM CST
Stocks with insider trader activity include CVT, ARAY and AMGN
CVT: 27.66 (+0.26), AMGN: 160.67 (+3.15), ARAY: 7.54 (+0.19)
Varian Medical (VAR) to Display New Technologies at RSNA - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 12:50PM CST
Varian Medical Systems (VAR) will showcase new technologies in the ongoing (Nov 30 through Dec 5) annual meet of the Radiological Society of North America (RSNA).
VAR: 88.44 (+0.69), EW: 130.75 (+1.17), ARAY: 7.54 (+0.19), ANGO: 19.19 (+0.33)
OKS, XPO, XPH, WU, MVO, ARAY Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Dec 03, 7:24AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ONEOK PARTNERS, L.P. (NYSE:OKS), XPO Logistics Inc (NYSE:XPO), Spdr S&P Pharmaceuticals Etf (NYSE:XPH), Western Union Co (NYSE:WU), MV Oil Trust (NYSE:MVO), Accuray Inc (NASDAQ:ARAY) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
WU: 18.07 (-0.05), OKE: 50.71 (+0.33), XPH: 107.77 (+1.13), OKS: 41.05 (-0.04), ARAY: 7.54 (+0.19), MVO: 14.34 (-0.60), XPO: 41.97 (-0.51)
Accuray Has Returned 18.0% Since SmarTrend Recommendation (ARAY)
Comtex SmarTrend(R) - Mon Dec 01, 5:21PM CST
SmarTrend identified a Downtrend for Accuray (NASDAQ:ARAY) on July 18th, 2014 at $8.11. In approximately 5 months, Accuray has returned 17.95% as of today's recent price of $6.65.
ARAY: 7.54 (+0.19)
Accuray and Lausanne University Hospital Join Forces to Offer Patients Personalized Radiation Therapy Treatments
PR Newswire Europe - Wed Nov 26, 9:02PM CST
- Collaboration Increases Patient Access to the CyberKnife(R) and TomoTherapy(R) Systems
ARAY: 7.54 (+0.19)
3 Reasons Obamacare Could Be Doomed in Its Second Year
Sean Williams, The Motley Fool - Motley Fool - Thu Nov 20, 8:36AM CST
Source: White House on Flickr. It's been five days since the Affordable Care Act's online marketplaces began enrolling Americans for health insurance in 2015, and perhaps the most amazing aspect of the launch thus far is that it's been largely...
CI: 104.23 (-0.08), HCA: 74.89 (-0.11), ARAY: 7.54 (+0.19), AET: 89.59 (+0.14), WLP: 128.71 (+0.94)
Accuray CyberKnife M6 System Now Available in Manhattan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 5:05PM CST
Developer of radiation therapy systems, Accuray Inc (ARAY) recently announced that Winthrop University Hospital's NYCyberKnife Center has started treating patients with the company's CyberKnife M6 System.
VAR: 88.44 (+0.69), ISR: 1.54 (+0.04), ARAY: 7.54 (+0.19)
First CyberKnife® Full-Body Radiosurgery System in Manhattan Now Treating Patients
PR Newswire - Tue Nov 18, 7:30AM CST
Accuray Incorporated (Nasdaq: ARAY) announced today that the first CyberKnife® System in Manhattan is now treating patients at Winthrop University Hospital's NYCyberKnife Center. Winthrop's decision to install the latest generation CyberKnife M6(TM) System reinforces its growing reputation as a dedicated radiosurgery device that delivers extremely precise full-body treatments while maximizing patients' quality of life during and after treatment.
ARAY: 7.54 (+0.19)
Downtrend Call Working As Accuray Stock Falls 13.0% (ARAY)
Comtex SmarTrend(R) - Fri Nov 14, 9:38AM CST
SmarTrend identified a Downtrend for Accuray (NASDAQ:ARAY) on July 18th, 2014 at $8.11. In approximately 4 months, Accuray has returned 13.02% as of today's recent price of $7.05.
ARAY: 7.54 (+0.19)
Accuray to Participate in Brean Capital's 2014 Life Science Conference
GlobeNewswire - Mon Nov 10, 3:10PM CST
Accuray Incorporated (Nasdaq:ARAY), announced today that its management is scheduled to participate in the Brean Capital 2014 Life Science Conference in New York City on Monday, November 24, 2014.
ARAY: 7.54 (+0.19)
VYCOR: "On the Cusp of the Next Big Healthcare Trend"
ACCESSWIRE - Mon Nov 10, 8:23AM CST
Vycor: "On the Cusp of the Next Big Healthcare Trend"
MDVN: 99.23 (+1.23), ABMD: 38.46 (+0.13), JNJ: 104.59 (+0.31), AMGN: 160.67 (+3.15), EXAS: 27.60 (+0.39), ARAY: 7.54 (+0.19), HOLX: 26.89 (+0.10), PBYI: 189.96 (+0.12)
